HIF-1 versus HIF-2-specific activation is determined, at least in part, by factors within the tumor microenvironment such as intensity and duration of hypoxia, as well as cell-type-specific pathway activation within both tumor cells and those of the complex tumor microenvironment [14–16]. The gene discussed is HIF1A; the disease is neoplasm.